- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ 16.0898 ↑ 0.09%
[as on 14 November, 2025]
NAV chart with SMA (Simple moving average) overlay
SMA (Simple Moving Average)
Returns
| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|
| quant Healthcare Fund - Growth Option - Direct Plan | -1.73% | 0.09% | 2.09% | 0.44% | 3.32% | -0.75% | - | - | - | - |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|
| 82.16% |
4.18% (Arbitrage: 0.00%) |
0.00% |
0.00% |
1.21% |
Equity
| Name | Symbol / ISIN | Sector | Weight % | Quantity | Qty change % |
|---|
| Aster DM Healthcare Limited | ASTERDM (INE914M01019) | Healthcare Services | 10.37% | 626765 | -2.40% |
| RPG Life Sciences Limited | RPGLIFE (INE105J01010) | Pharmaceuticals & Biotechnology | 8.88% | 150529 | - |
| Zydus Wellness Ltd | ZYDUSWELL (INE768C01028) | Food Products | 7.74% | 641730 | - |
| Sequent Scientific Limited | SEQUENT (INE807F01027) | Pharmaceuticals & Biotechnology | 7.26% | 1477126 | - |
| ANTHEM BIOSCIENCES LIMITED | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 6.70% | 333554 | +4.24% |
| Pfizer Ltd | PFIZER (INE182A01018) | Pharmaceuticals & Biotechnology | 6.37% | 47954 | - |
| Aurobindo Pharma Limited | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 6.22% | 217300 | - |
| Alivus Life Sciences | ALIVUS (INE03Q201024) | Pharmaceuticals & Biotechnology | 6.04% | 246298 | - |
| HDFC Life Insurance Co Ltd | HDFCLIFE (INE795G01014) | Insurance | 5.94% | 297406 | - |
| SMS Pharmaceuticals Limited | SMSPHARMA (INE812G01025) | Pharmaceuticals & Biotechnology | 5.40% | 833213 | - |
| Concord Biotech Limited | CONCORDBIO (INE338H01029) | Pharmaceuticals & Biotechnology | 3.63% | 83472 | - |
| Sun Pharmaceutical Industries Limited | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 3.25% | 77249 | - |
| Lupin Limited | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 2.87% | 56976 | - |
| Gland Pharma Limited | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 1.48% | 28076 | - |
Debt
| Name | Rating | Weight % |
|---|
| 91 Days Treasury Bill 18-Dec-2025 | N.A. | 1.83% |
| 91 Days Treasury Bill 20-Nov-2025 | N.A. | 0.79% |
| 91 Days Treasury Bill 28-Nov-2025 | N.A. | 0.79% |
| 91 Days Treasury Bill 04-Dec-2025 | N.A. | 0.78% |
Portfolio data is as on date 30 September, 2025
NAV (Net asset value) history
quant Healthcare Fund - Growth Option - Direct Plan - 30 days NAV history
| Date | NAV |
|---|
| 14 November, 2025 | 16.0898 |
| 13 November, 2025 | 16.0754 |
| 12 November, 2025 | 16.0822 |
| 11 November, 2025 | 15.9113 |
| 10 November, 2025 | 15.9775 |
| 7 November, 2025 | 15.7611 |
| 6 November, 2025 | 15.7264 |
| 4 November, 2025 | 15.9346 |
| 3 November, 2025 | 16.0358 |
| 31 October, 2025 | 15.9492 |
| 30 October, 2025 | 16.0398 |
| 29 October, 2025 | 16.1227 |
| 28 October, 2025 | 16.0037 |
| 27 October, 2025 | 16.0462 |
| 24 October, 2025 | 16.0411 |
| 23 October, 2025 | 16.1291 |
| 20 October, 2025 | 16.0888 |
| 17 October, 2025 | 16.0884 |
| 16 October, 2025 | 16.2073 |
| 15 October, 2025 | 16.1066 |
| 14 October, 2025 | 16.0193 |
| 13 October, 2025 | 16.2532 |
| 10 October, 2025 | 16.203 |
| 9 October, 2025 | 16.0734 |
| 8 October, 2025 | 15.9038 |
| 7 October, 2025 | 15.844 |
| 6 October, 2025 | 15.8637 |
| 3 October, 2025 | 15.8519 |
| 1 October, 2025 | 15.7496 |
| 30 September, 2025 | 15.4881 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of quant Healthcare Fund - Growth Option - Direct Plan?
The latest NAV of quant Healthcare Fund - Growth Option - Direct Plan is 16.0898 as on 14 November, 2025.
What are YTD (year to date) returns of quant Healthcare Fund - Growth Option - Direct Plan?
The YTD (year to date) returns of quant Healthcare Fund - Growth Option - Direct Plan are -1.73% as on 14 November, 2025.
What are 1 year returns of quant Healthcare Fund - Growth Option - Direct Plan?
The 1 year returns of quant Healthcare Fund - Growth Option - Direct Plan are -0.75% as on 14 November, 2025.